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Abstract 
Background: Incidence and mortality from sudden cardiac arrest is high, making it a 
prevalent cause of death. Both incidence and survival rates show great variability 
between populations. In order to improve survival from sudden cardiac arrest, it is 
necessary to view aetiology, treatment effects, and outcome as a whole. 
Aim: To investigate cardiac arrest incidence, treatment, and outcome in one 
geographic area during a limited period of time. 
Method: Paper I and Paper II prospectively included consecutive patients suffering 
cardiac arrest in one of our local hospitals, or in the geographical area delivering 
patients to these hospitals, between 1 December 2008 and 30 November 2009. Paper 
I compared out-of-hospital cardiac arrest with in-hospital cardiac arrest in terms of 
Utstein characteristics and survival. Paper II compared cognitive function in cardiac 
arrest survivors with good neurologic outcome at hospital discharge with an age- and 
gender-matched reference population. Paper III retrospectively examined consecutive 
out-of-hospital cardiac arrest survivors from December 2003 to December 2008 
admitted to the emergency department in a comatose state. Propensity score matching 
was used to compare intensive care treatment including targeted temperature 
management with intensive care treatment not including targeted temperature 
management in regard to survival. 
Results: The incidence was 60.6 per 100.000 person-years for out-of-hospital cardiac 
arrest and 41.3 per 100.000 person-years for in-hospital cardiac arrest. Survival to 
hospital discharge was 16.2% for in-hospital cardiac arrest and 16.8% for out-of-
hospital cardiac arrest. Pooled mortality from cardiac arrest in our community was 
85.0 per 100.000 person-years. Four years after cardiac arrest, 29% of patients had 
mild cognitive impairment. Restricted mean survival time increased by 57 days as a 
result of targeted temperature management. Standardised mortality ratio was 2.8 for 
cardiac arrest survivors over the first four years following hospital discharge, 
compared with an age- and gender-matched normal population. 
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Conclusion: Survival to hospital discharge was similar between in-hospital and out-
of-hospital cardiac arrest. The majority of cardiac arrests occurred out-of-hospital. 
Nearly one-third of patients with good cerebral outcome on hospital discharge had 
mild cognitive impairment four years after cardiac arrest. Targeted temperature 
management increased survival after cardiac arrest. 
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ECMO Extracorporeal membrane oxygenation 
EMS Emergency Medical Service 
GCS Glasgow coma score 
HADS Hospital anxiety and depression rating scale 
ICU Intensive care unit 
IHCA In-hospital cardiac arrest 
MCI Mild cognitive impairment 
OHCA Out-of-hospital cardiac arrest 
PCI Percutaneous coronary intervention 
PEA Pulseless electric activity 
TTM Targeted temperature management 
VF Ventricular fibrillation 
VT Ventricular tachycardia 
UK United Kingdom 
US United States of America 
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1. Introduction 
The title of this dissertation is broad because my research in cardiac arrest (CA) is not 
concerned with one single topic which I focus upon very closely and discuss in 
minute detail. Rather, I attempt to pan out in order to get an understanding of the big 
picture. Research in CA deals with unexpected death, cases where there is no medical 
history which would lead anyone to believe that death is imminent. The dissertation 
discusses some of the challenges with research in this population. 
 
1.1 Classification and aetiology of cardiac arrest 
The Utstein template for uniform reporting of data from out-of-hospital cardiac arrest 
was published in 1991 as a result of panel discussions between experts in the field.4 
The publication clearly defined the terminology used in CA research, highlighted 
important structural parameters which should be reported, and defined a set of 
standardised outcome measures so that future reports would be comparable. (Figure 
1, Appendix 8.1) According to the revised Utstein template published in 2004, CA is 
the cessation of cardiac mechanical activity as confirmed by the absence of signs of 
circulation. These signs of circulation include breathing (more than the occasional 
gasp), coughing, or movement. For healthcare personnel, signs of circulation may 
also include evidence of a palpable pulse or a measurable blood pressure.5, 6 
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Fig. 1. Utstein reporting template for core data elements 
 
Although the definition is clearly stated, a clinical definition like this one poses 
problems. Firstly, the clinical condition of CA may arise from different causes. 
Secondly, it may be difficult to determine the exact duration of symptoms before CA, 
especially if the event was not observed.7 As a consequence, several approaches to 
define the population of interest have emerged in CA research. 
One approach is to include sudden and unexpected causes of CA in which the 
emergency medical team judges that cardiopulmonary resuscitation (CPR) is 
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warranted. The term “sudden cardiac arrest” has been used to describe this 
population. It has been in use sporadically since the 1960’s and more regularly 
following the landmark publication “Improving survival from sudden cardiac arrest: 
the "chain-of-survival" concept” by the American Heart Association in 1991.8 
Although the term excludes events that are not medical emergencies, it includes 
patients with vastly differing aetiology. Apart from cardiac causes, CA from 
respiratory, traumatic, metabolic and toxic causes fall within the definition. There is 
also no clear definition of how abrupt an event needs to be for it to fall within the 
definition of sudden cardiac arrest.  
Another approach is to include CA of cardiac causes only. The term “sudden cardiac 
death”, coined by cardiologists in the late 1970’s, has been used in conjunction with 
this population. Sudden cardiac death describes the unexpected death from a cardiac 
cause within a short time period, generally less than one hour from the onset of 
symptoms, in a person without any prior condition that would appear fatal.9 This 
definition is more precise, defining a more homogenous population than sudden 
cardiac arrest. Further exploration, however, reveals again the problems of a clinical 
definition. Essentially different conditions like arrhythmia, cardiomyopathy, valvular 
disease and coronary disease contribute to the population. 9 (Figure 2) Some 
researchers therefore choose to include patients with sudden cardiac death and 
primary ventricular fibrillation (VF) only. A consequence of this approach is a 





A third approach is to separate out-of-hospital cardiac arrest (OHCA) from in-
hospital cardiac arrest (IHCA). Traditionally, CPR was performed by direct open-
chest heart compressions and ventilation via an endotracheal tube in a hospital 
setting.10 Modern CPR techniques comprising closed-chest compressions, external 
defibrillation, mouth-to-mouth ventilation and bag-mask ventilation emerged in the 
1950s and 1960s.10-14 As community emergency medical teams emerged, several 
educational programs were launched in order to teach these skills to emergency 
Fig. 2 
 
Reprinted with permission from DP Zipes and Wolters Kluwer 
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medical technicians and bring CPR out to the public.15 Outcome reports from OHCA 
were published, and it has since remained common to distinguish OHCA from 
IHCA.16 The Utstein templates for reporting on cardiac arrest outcomes maintain the 
separation, perhaps because the two populations are intuitively different.4, 5, 17 Direct 
comparisons between the two populations, however, are sparse.18, 19 
It is common in epidemiological studies to include all CA patients assessed by 
emergency medical services (EMS), whether they are treated or not.20 This approach 
avoids selection bias when comparing EMS. Still, incidence will be affected by local 
routines for involvement of EMS.21 Patients with unwitnessed CA discovered when 
they are obviously dead are often missed. These patients may be found using death 
certificates. The best solution for identifying the vast majority of CA patients for 
epidemiological purposes is to combine information from several sources, including 
EMS, death certificates, and results from post-mortem investigations.22 
1.2 Incidence rates 
Bearing in mind the various definitions of CA, reports of varying incidence are to be 
expected. Around the globe, CA incidence varies from 28.3 per 100.000 person-years 
in Asia to 54.6 per 100.000 person-years in North America.23 Within Europe, 
incidence rates vary from 28 to 244 per 100.000 person-years, averaging at 84 per 
100.000 person-years.24 A similar variation is reported for IHCA, where rates vary 
from 1.3 to 4.0 per 1000 admissions.25-29 
Many publications report incidence rates unadjusted for the age and gender 
composition of the study population. This is problematic because population 
characteristics vary, even within the same country.30 When adding differences in how 
EMS are organized, it becomes evident that incidence rates will vary, and comparison 
is difficult. 
While heterogeneous study populations may account for some of the differences, an 
argument can be made that CA incidence is variable. This is supported in a registry-
based study which demonstrates varying OHCA incidence rates across North 
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America.31 A study using geographic information systems revealed varying incidence 
rates even within communities.32 A reason for some of the variation may be 
socioeconomic status, which is commonly omitted from studies, but has been found 
to have impact on CA incidence rates.27, 32-34  
The difference in incidence for IHCA between the United Kingdom (UK) and the 
United States of America (US) may serve as an example.27, 35 Both being developed 
countries, one would expect similar incidence rates. Yet the UK incidence rate is 1.6 
per 1000 hospital admissions while the US incidence rate is 2.85 per 1000 hospital 
admissions. The UK report includes all IHCA attended to by a hospital-based 
resuscitation team in response to an emergency call. The US report includes all 
patients ≥18 years of age who underwent CPR for IHCA according to diagnose codes 
in the Nationwide Independent Sample, the largest publicly available all-payer 
inpatient care database in the US. Since CA in children has a lower incidence than 
CA in adults, the inclusion of children to the study population will lower the overall 
incidence. This illustrates a difference in methodology. While the UK report is based 
on collection of data specifically for the UK National Cardiac Arrest Audit, the US 
report is based on data extracted from a general inpatient database. As a result, it is 
difficult to conclude whether incidence rates are different or not between the UK and 
the US. 
1.3 Resuscitation effort 
Cardiac arrest patients are resuscitated according to a standard procedure described in 
guidelines for resuscitation.36 The guidelines are more or less uniform worldwide due 
to collaboration via the International Liaison Committee on Resuscitation (ILCOR), 
although some modifications exist.37 The recent guidelines issued by the European 
Resuscitation Council have a broad scope. They focus on technical, educational, 
community, and ethical aspects.38-40 This is a consequence of the chain-of-survival 
concept, which states that good outcome from CA depends on good performance in 
each link in the chain of events from CA to full recovery.8, 41 In order to maximise the 
potential for good outcome there has to be a rapid activation of EMS. Emergency 
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medical dispatchers must rapidly recognize CA, initiate a timely response and 
emergency teams must arrive swiftly on scene. Bystanders need to start CPR 
immediately after alerting the EMS, preferably using an automated external 
defibrillator (AED) which has been made publicly available. Emergency medical 
teams need to have good technical skills in order to achieve return of spontaneous 
circulation (ROSC). Post ROSC care must meet high standards so that patients 
survive to discharge. Finally, there has to be good follow-up after discharge to ensure 
the best physical and cognitive recovery for each individual patient. 
The 2015 guidelines identify areas of improvement based on available evidence. 
These include recommendations to increase bystander CPR and to improve 
performance of the EMS. There is a continued focus on good quality chest 
compressions and reduction of hands-off time as well as early defibrillation. There is 
also a trend towards using novel technologies such as ultrasound and capnography to 
identify precipitating causes of cardiac arrest and to guide prognostic decisions 
during CPR.36 
Although these recommendations are clearly stated and based on the best evidence 
available, they do not necessarily reflect the need for improvement in local or 
national organizations. A weak link in the chain of treatment in one system may be 
strong in another. Both systems may have potential for improvement, but the way to 
achieve improvement differs. The complexity is illustrated in a study from Texas in 
the US where neighbourhood-level race and income characteristics within the same 
EMS system are shown to influence rates of bystander CPR.42 In order to improve 
one must start with a good knowledge of the shortcomings in the local treatment 
chain. Given that prerequisite, community programs aimed at improving links in the 
treatment chain may increase survival from CA.43 
1.4 Post ROSC treatment 
The evolution of catheter technology during the past two decades has made 
percutaneous coronary intervention (PCI) increasingly available. As a result many 
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CA patients may be transported directly to a PCI centre for intervention. Prevalence 
of coronary disease in OHCA survivors  without obvious non-cardiac aetiology is 
approximately 65% with PCI being performed in approximately 40%.44 Although the 
predictive value of electrocardiogram (ECG) changes in CA survivors is low, current 
practise is to offer emergent coronary angiograms with immediate PCI if necessary in 
CA survivors with novel ST segment elevations or left bundle branch block in their 
ECG.45, 46 Coronary angiograms in patients without ECG changes are controversial 
due to conflicting evidence.47, 48 Factors like primary heart rhythm, witnessed arrest, 
time to ROSC, circulatory stability and cerebral function are taken into consideration 
in order to decide which of these patients are likely to benefit from PCI.45 
The introduction of targeted temperature management (TTM) occurred in parallel 
with the evolution in catheter-based coronary interventions and was introduced to 
clinical practice following the publication of two controlled studies in 2001, one 
randomised and one pseudorandomised.49, 50 Despite early reports of benefit, 
systematic reviews revealed a low quality of evidence and risk of bias at some level 
in all randomised studies.51-53 This led to the publication of a randomised controlled 
trial comparing TTM at 33 and 36 °C in which no differences in mortality or 
cognitive functions were found.54, 55 As a result, guidelines now recommend TTM at 
32 to 36 °C for comatose CA survivors instead of the previous suggestion of TTM at 
32 to 34 °C.45, 56 Evidence is limited regarding when to initiate TTM, which 
temperature to target, and duration of TTM. 
A thorough review of which aspects of intensive care therapy might influence 
outcome in CA patients is beyond the scope of this dissertation. However, it should 
be mentioned that CA survivors are complex patients. Patients with post CA 
syndrome have similarities with septic patients, patients with heart failure, and 
patients with cerebral injury.57 Consequently, many aspects of intensive care 
treatment potentially influence outcome.  
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1.5 Outcome measures 
Cardiovascular disease is the most common cause of death in Europe today, with 
ischaemic heart disease accounting for approximately 125 age- and population 
adjusted deaths per 100.000 person-years.58 The figure includes both patients dying 
from unexpected CA and patients with chronic disease following its natural course. 
Survival is the traditional outcome measure from CA. It is often reported as survival 
of the event, survival to hospital discharge, or survival to a defined point in time after 
CA.27, 35 These data are readily available, but as reliable outcome measures they fall 
short. Survival to hospital discharge does not take into account that the time to 
discharge following CA may vary between subjects and between health care systems. 
As a consequence, direct comparisons of survival to hospital discharge are not 
necessarily valid. Survival to a defined point in time after CA, typically 30 days, 
takes accounts for variable discharge routines, but does not differentiate between 
deaths at different times between CA and follow up. With a 30 day follow-up, for 
instance, the analysis does not differentiate between a patient dead on the day of CA 
and a patient dead on day 29 after CA. A better solution would be to use more 
sophisticated survival analyses, which would give a better approximation of 
survival.59 
Brain function is another important outcome measure from CA. The brain is 
particularly vulnerable to hypoxia. Within minutes, untreated CA leads to global 
brain ischemia with a rapid progress towards brain death. Introduction of new CPR 
techniques such as defibrillation, mouth-to-mouth ventilation and closed-chest 
compression in the 1950s and 1960s gave CA victims a chance of surviving the initial 
event and be admitted to hospital.60 10, 61 Hospital wards providing intensive 
monitoring and specialised care emerged. Even though patients started surviving to 
hospital discharge, good neurological outcome was not always the case.62 This 
spurred an interest in brain resuscitation among critical care investigators.63 In order 
to standardize assessment of outcome after severe brain damage, the Glasgow 
outcome scale (GOS) was introduced.64 A Pittsburgh modification, the Cerebral 
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Performance Category scale (CPC) was included in the Utstein guidelines as a 
meaningful outcome measure describing brain function in resuscitation research.4, 65 
The CPC has five categories, ranging from normal brain function (1) to brain death 
(5). This crudeness does not allow a detailed description of  brain function, and 
research on cognitive outcome in CA survivors has relied on neuropsychological 
testing to provide more thorough assessments.66 While neuropsychological tests 
provide detailed assessments of brain function, they are not suited to larger trials or 
clinical practice because they are time consuming and depend on specially trained 
personnel. This has led to an interest in cognitive tests which are more easily 
administered. Recently, there has been an interest in computerized 
neuropsychological assessment devices.67, 68 
The increasing number of CA survivors with good brain function has prompted 
research into patient-reported outcome measures. This is a broad field of research, as 
the World Health Organization defines health as “a state of complete physical, mental 
and social well-being and not merely the absence of disease or infirmity”.69 
Consequently, a large number of instruments are available to assess patient-reported 
outcome measures. Each individual instrument focuses on different aspects of health. 
The aspects include physical function and symptoms, self-rating of health, 
satisfaction with care, psychological and social well-being, role activities, personal 
constructs, and cognitive function. 
Based on their focus, instruments are generally divided into generic and specific 
tools. Generic instruments assess aspects of health which have broad relevance, such 
as physical and social function and psychological well-being. Generic tools have the 
potential to assess side effects of treatment on health, but may lack relevance and 
responsiveness to issues concerning a specific condition. Specific instruments assess 
aspects of health of special importance to a specific patient group, a specific disease 
or a specific health domain.70 Specific instruments are targeted, relevant, and 
responsive, but have limited potential to capture unexpected side effects of treatment. 
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Generic and specific instruments are complementary. A complete picture of health 
state is acquired only if both types of instruments are used. Some of the generic 
instruments include population norms with which the study population may be 
compared.71, 72  In general, instruments which allow comparison to a norm may be of 
preference to those who do not. The drawback is that some of these tools are 
commercial and impose a cost to research and clinical practice. 
1.6 Temporal trends 
Even when comparing results from the same healthcare system, temporal trends 
introduce complexity. 
Improved prevention increases life expectancy and changes the burden of disease. 
This means that the population at risk changes with time, which has a direct effect on 
incidence and outcome from CA.73-75 New treatment strategies also improve survival 
with time.47 Patients who survive from illness or disease due to new treatment 
become part of the population at risk after discharge, causing a further change in the 
population at risk.76  
The health care system itself also changes with time. Many EMS have implemented 
improvements in their local treatment protocols inspired by the chain-of-survival 
concept.8 Some EMS report substantial increases in survival after implementation.70, 
77 
1.7 Comparison between health systems 
From the previous sections it should be evident that comparison between health 
systems is difficult due to the number of factors which influence incidence and 
outcome. As a minimum, the composition of the study population and a description 
of the health care system in which the study was undertaken should be reported. For 
better comparison, estimates of incidence and outcome should be standardised.78 The 
process of standardisation adjusts estimates according to a population with different 
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characteristics than the study population. The European Standard Population, for 
instance, standardises according to age.79 Estimates from research populations with 
differing age compositions are better compared if both have been standardised to the 





The overall aim of the dissertation was to investigate CA incidence and outcome in a 
limited geographic area during a restricted period of time. This allowed us to reduce 
the effects of time and population characteristics on outcome measures. 
 
Aims of each paper were as follows: 
Paper I 




The primary objective was to test the hypothesis that cognitive impairment persists in 
CA survivors with good outcome according to the CPC scale. Secondary objectives 
were to investigate health-related quality of life and whether cognitive function after 
CA could be predicted. 
 
Paper III 
The primary objective was to test the hypothesis that TTM improves survival after 
CA in clinical practice. The secondary objective was to investigate treatment effect of 






Prospective population-based cohort study. 
Paper II 
Prospective population-based cohort study. 
Paper III 
Retrospective population-based cohort study. 
 
3.2 Populations 
The Bergen region comprises 15 counties with 372.651 inhabitants as of 1 January 
2009 populating an area of 3294 km2 of which 3125 km2 is dry land (Statistics 
Norway, 2009). The population density is sparse, with a mere 119 persons per km2 of 
dry land. Western Norway has a challenging geography with mountains, islands and 
fjords, generating a coastline of 5064 km in our catchment area. There are two 
hospitals in the Bergen region. Haukeland University Hospital is a tertiary teaching 
hospital with approximately 62.000 admissions a year. Haraldsplass Deaconess 
Hospital is a local area hospital with around 11.000 admissions a year. Both hospitals 
recruited patients for papers I and II, while patients for paper III were recruited from 




We included unconscious patients with abnormal breathing where basic life support 
(BLS) was initiated either by lay or trained personnel in the Bergen area from 1 
December 2008 to 30 November 2009. Patients with suspected CA of all aetiologies, 
both in-hospital and out-of-hospital, were included. Resuscitation of newborns was 
not included. Employment of an AED only was not defined as BLS. Patients who 
were most likely dead before the start of BLS as judged by the EMS or the cardiac 
arrest team (CAT) and patients judged by the study group to have suffered only 
respiratory arrest were excluded. Patients suffering CA of duration less than three 




Patients discharged alive after cardiac arrest in Bergen between 1 December 2008 and 
30 November 2009, above the age of 18, and alive in October 2012 were considered 
for inclusion. Patients with cerebral performance category (CPC) above 2 on hospital 




Survivors from OHCA available for targeted temperature management (TTM) in the 
emergency department of Haukeland University Hospital between December 2003 
and December 2008 were considered for inclusion. Patients with Glasgow Coma 
Score (GCS) > 8 and patients with coagulopathy or terminal illness were excluded. 
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3.3 Interventions and control groups 
 
Paper I 
The paper compared IHCA with OHCA in the geographical area served by Helse 
Bergen Hospital Trust. 
 
Paper II 
Cognitive function in survivors from CA was compared with an age- and gender-
matched normative sample consisting of British controls. Health-related quality of 
life in CA survivors was compared with an age- and gender-matched Danish 




Patients receiving intensive care treatment including TTM were compared with 
patients receiving intensive care treatment not including TTM in the same hospital 
during the same time period. TTM was induced using axillary and femoral ice bags 
before hospital admission and cold saline after admission until invasive TTM was 
established. The CoolGard Temperature Management System with ICY Catheters 
(Zoll Medical Corporation, MA, USA) was used for invasive TTM. Patients were 
cooled to 33 °C at a rate of 0.5 °C per hour and maintained at 33 °C for 24 hours 
before rewarming at a rate of 0.5 °C per hour to 37 °C. Seven patients included in the 
intervention group received surface cooling because invasive cooling was 
unavailable. In these seven patients, TTM was established using active cooling 
garments in five patients, ice bags and cold towels in one patient, and ice bags alone 




The primary end point was survival to hospital discharge. 
 
Paper II 
The primary end point was cognitive impairment as measured by the Cambridge 
Neuropsychological Test Automated Battery (CANTAB) (Cambridge Cognition, 
Tunbridge Court, Tunbridge Lane, Bottisham, Cambridge CB25 9TU). Secondary 
outcome was health-related quality of life as measured by the EQ-5D-5L 




The primary end point was restricted mean survival time, defined as the number of 
days alive after CA limited to a maximum value of 365 days. The secondary end 
point was mean CPC score. 
  
3.5 Data acquisition  
Paper I 
Utstein plots supplied by the helicopter emergency medical service provided data in 
the majority of OHCA. Data regarding IHCA was primarily obtained from the 
electronic patient journal. Several sources were screened in order to identify missing 
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cases and to find missing data. Resuscitations occurring physically on hospital 
grounds were allocated to the in-hospital group according to Utstein criteria.5  
 
Paper II 
The Hospital Anxiety and Depression rating Scale (HADS) (Ageing and health, Oslo 
University Hospital, Ullevål, Bygn. 37, 0407 Oslo, Norway) and the EQ-5D-5L were 
sent by post to all eligible patients, along with written information about the study, a 
consent form and a pre-paid return envelope. Participants who returned the initial 
forms were contacted by telephone to schedule cognitive testing. Participants who did 
not return the forms were contacted by telephone for consent. If consent was given, 
they were reminded to return the forms and cognitive testing was scheduled. 
CANTAB test sessions took place at Haukeland University Hospital and lasted 
approximately one hour. For participants unable to travel to the hospital, testing was 
arranged at a health facility closer to their residence. 
 
Paper III 
Data were collected retrospectively from the patient medical journals and local 




Numerical data are presented as median (inter-quartile range) with analysis using the 
Students t-test if normally distributed or the Mann-Whitney U-test if not normal. P-
values < 0.05 were considered significant. Proportions were analysed using the chi-




Mean scores are reported with the 95% confidence interval in brackets. Categorical 
data were analysed using chi-squared tests without continuity correction, and 
confidence intervals for the difference between proportions were calculated using the 
Agresti-Caffo method.80 Correlations were calculated using Pearson’s product-
moment correlation. Simple and multiple regressions were performed to investigate 
whether cognitive function could be predicted. Survival data were retrieved from the 
electronic patient journal and compared to Norwegian life tables.81 Life tables for 
2009 were used for subsequent years since more recent tables were unavailable at the 
time of analysis. All statistical analyses were conducted in R version 3.1.1.82 
 
Paper III 
Initial comparisons between treatment groups were performed using t-tests for 
continuous variables and chi-squared test for discrete variables. All baseline variables 
affecting both treatment and outcome are potential confounders and were considered 
for inclusion in the propensity score model. Due to the small data set, variables only 
weakly associated with outcome were excluded.83 Potential confounders included in 
the analysis were: age, gender, shockable primary rhythm, witnessed CA, bystander 
CPR, time from CA to professional CPR, time from CA to ROSC, smoking status, 
known diabetes mellitus, known hypertension, and previous myocardial infarction. 
Because of low counts in some categories, smoking was recoded from four to three 
categories and hypertension from three to two categories. Time from CA to ROSC 
was winsorised to 60 minutes (i.e. longer times were replaced by 60 minutes). 
For predictors with less than 10 missing values, the observations with missing data 
were discarded. For continuous predictors with more than 10 missing values, missing 
values were replaced by fixed values and indicator variables for ‘missing’ were 
included in the model. For categorical predictors with more than 10 missing values, 
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‘missing’ was treated as a separate category.84, 85 See Figure 5 for a flowchart of the 
data used. 
The propensity score was modelled using logistic regression. To ensure that the 
model was flexible enough to accurately predict treatment, we used second-degree 
polynomial terms for all three continuous variables. The distribution of the propensity 
score in the treatment groups was examined to ensure adequate overlap. Balance 
checks were based on examining means, proportions, and distributions of predictors 
before and after matching.83 
Non-treated subjects were matched 1:1 to treated subjects within callipers, using a 
best-first (‘greedy’) algorithm. The calliper width for matching was set to 10% of the 
standard deviation of the logit of the propensity score since the common rule of 20% 
did not adequately balance the predictors. 
Survival was compared using mean values restricted to a maximum of 365 days.86 
The treatment effect was estimated using a linear mixed-effects model with a random 
intercept for each matching pair. For comparison purposes, we also report the results 
from a naïve t-test (ignoring any confounders), and from an ordinary least-squares 
model, where we adjust for confounders by including the same predictors in the same 
form as in the propensity score model. 
 Stata SE version 14.0 (StataCorp LP, Texas, USA) and R version 3.2.3 with the 
‘nonrandom’ package version 1.42 were used for data analysis.87, 88 
3.7 Ethics 
Paper I 
The study was conducted with the approval of the Norwegian Directorate of Health 
[08/6690;  12 November 2008], the Norwegian Social Science Data Services 
[18919/2/LT; 5 May 2008] and the Regional Ethics Committee [REK Vest, 
Universitetet i Bergen, Det medisinske fakultet, Postboks 7804, 5020 Bergen; 
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protocol number 073/08; 8 April 2008]. Patients surviving to hospital discharge gave 
their informed consent. 
 
Paper II 
The study was conducted in accordance with the protocol approved by the Regional 
Committee for Medical and Health Research Ethics (2012/1701/REK Vest). Written 
consent was obtained from all subjects. 
 
Paper III 
The study was approved by the privacy ombudsman in Helse Bergen Hospital Trust 
and judged not to need approval in the regional ethics committee. (Approval no. 
2014/20465) 
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4. Synopsis of results 
4.1 Paper I 
A total of 430 patients were considered for inclusion, of which 380 were finally 
included. (Figure 3) The study population included six patients under the age of 18; 
the youngest patient aged six at the time of CA. The incidence of CA was 60.6 per 
100.000 person-years for OHCA and 2.10 per 1000 admissions for IHCA. The 
helicopter emergency medical service unit responded to 128 of 226 OHCA (56.6%). 
The OHCA population was significantly younger and had a wider age span than the 
IHCA population. No significant differences were found in terms of gender, 
shockable primary rhythms or presumed cardiac aetiology. The proportion of patients 
with pulseless electric activity (PEA) was smaller for OHCA compared with IHCA. 
IHCA was more often witnessed and had higher proportions of professional first 
rescuers. Bystander CPR and bystander DC shock before arrival of CAT or EMS 
were also higher for IHCA. The median time from CA to start of CPR and the 
duration of professional resuscitation for IHCA was significantly shorter than the 
corresponding values for OHCA. Termination of resuscitation due to comorbidity 
was more frequent for IHCA compared with OHCA. 
There was a higher proportion of any ROSC for IHCA compared with OHCA. There 
were no differences between the groups regarding sustained ROSC or survival to 
hospital discharge. There was no difference in survival for subgroups VF/VT, CA of 
cardiac aetiology, or witnessed CA. The majority of survivors in both groups had a 
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Considered for inclusion 
430 
Resuscitation not attempted 
Dead   18 
 
Considered futile  11 
No cardiac arrest 
18 
Included 











n = 154 
OHCA 
n = 226 
Excluded 
Cardiac arrest during procedures  2 
 
Lack of consent       1 
Fig. 3. Flow chart showing included and excluded patients in Paper I. 
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4.2 Paper II 
Of the initial 61 CA survivors, one’s identity was unknown. 46 of the remaining 60 
were alive at the start of the study. Four had CPC > 2 on hospital discharge, one 
could not be reached, and 11 declined to participate. (Figure 4) 
Of the 30 included patients, 24 had coronary angiography performed during their 
hospital stay, while 16 had percutaneous coronary intervention performed. One 
patient had coronary artery bypass grafting performed, and seven were treated with 
TTM. The duration of resuscitation was longer among the included patients than 
among the patients who declined to participate or could not be reached. 
At the start of the study, 14 of 55 Norwegian patients with CPC ≤ 2 discharged alive 
with known identity were deceased. The expected number of deaths in an age and 
gender-matched Norwegian population was 5.0 (standardised mortality ratio: 2.8; 
95% CI: 1.6–4.5;  p<0.001).81 
The mean score for EQ-VAS was 70.6 (95% CI: 63.4 to 77.8), compared with 80.0 
(95% CI: 79.1 to 80.9) for an age and gender-matched Danish normal population.89 
The mean score for the EQ-index was 0.85 (95% CI: 0.79 to 0.90), compared with 
0.86 (95% CI: 0.85 to 0.87) for the same reference population. 
According to the criteria, 29% (8/28; 95% CI: 15%–47%) of the patients were 
cognitively impaired.90 In the multiple regression analysis, OHCA was a statistically 
significant predictor, with OHCA indicating better cognitive function. For reversal 
stages (stages 5, 7 and 9) of the Intra-/ Extradimensional set shift (IED), the mean 
number of errors was 18.7. For non-reversal stages (stages 4, 6 and 8), the mean 
number of errors was 16.1 (95% CI for difference: −1.4 to 6.5; p = 0.20). The total 
number of trials in IED intradimensional shift (ID, stage 6) was 6.5 versus 24.8 for 
the extradimensional shift (ED, stage 8) (95% CI for difference: 11.8 to 24.8; p < 
0.001) For the Delayed Matching to Sample (DMS) percentage correct at 0 seconds 
delay, the mean was 81.4 (95% CI: 75.4 to 87.5), whereas, at 12 seconds delay, the 




Fig. 4. Flow chart showing included and excluded patients in Paper II. 
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4.3 Paper III 
A total of 403 comatose CA patients were available for TTM in the study period. 
Exclusions due to study criteria numbered 57, while exclusions due to missing data 
numbered 10. (Figure 5) This left 336 patients eligible for inclusion in the propensity 
score model, 183 (54%) of them TTM-treated cases and 153 non-TTM controls. A 
crude comparison between treated cases and controls revealed significant differences 
in age, gender, primary rhythm, presumed cause of arrest, resuscitation, and medical 
history. The propensity score model developed to balance these differences satisfied 
the overlap assumption, i.e. treated cases and controls with similar propensity scores 
were available for matching. We successfully matched 96 treated cases with controls. 
The propensity scores had similar distributions in cases and controls after matching, 
and most baseline covariates were sufficiently matched. This indicates that the 
propensity score model was adequately specified and suited for causal inference. The 
estimation of treatment effects revealed that survival in the first year after CA 
(restricted mean comparison) increased by 57 days (95% CI: 12–103, p = 0.01) in 
TTM-treated cases. The mean CPC value at discharge was reduced by 0.5 (95% CI: 




 Fig. 5. Flow chart illustrating patients included in the propensity 
score model in Paper III. 
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5. Discussion 
This dissertation demonstrates similarities between IHCA and OHCA in terms of 
survival to hospital discharge. We present evidence that TTM in clinical practice had 
beneficial effects for comatose CA patients in terms of increased survival. When 
investigating long-term cognitive function in CA survivors, we found impaired short-
term memory similar to amnestic mild cognitive impairment (MCI). 
5.1 Epidemiology 
The incidence of EMS treated OHCA in paper I at 60.6 per 100.000 person-years is 
between the two most recent European estimates, and in line with recent registry 
publications from the US and Scandinavia.23, 24, 91, 92 The incidence of CA treated by 
the CAT was 2.10 per 1000 admissions. This is lower than in the US, but higher than 
in the UK.27, 35 In order to create OHCA and IHCA incidence rates which are easier to 
compare, we converted incidence per 1000 admissions to incidence per 100.000 
person-years in the general population served by Helse Bergen Hospital Trust. The 
171 IHCA correspond to an incidence of 41.3 per 100.000 person-years. When the 
numbers are presented this way, they communicate the relative incidence of OHCA 
and ICHA in a more understandable way. 
As mentioned in sections 1.2 and 1.7, it is not valid to directly compare crude 
estimates. In order to compare incidence rates, they should as a minimum be 
standardised to match the age composition of a reference population. Adjustment 
according to gender composition is desirable, as well as adjustment according to 
socioeconomic status. The latter, however, is difficult in European populations due to 
a lack of publicly available reference populations. Such information has proven 
beneficial in explaining county-level variation in survival in the US.93 
Knowing the prevalence of risk factors for cardiovascular disease in the research 
population would further help comparison. Several studies document the impact of 
reductions in cardiovascular risk factors on CA incidence and outcome. One study 
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found that favourable changes in cholesterol, smoking, physical activity and blood 
pressure reduced the incidence of coronary heart disease and out-of-hospital sudden 
death.94 Another study reported that smoking legislation had an impact on CA 
incidence.95 Next to standardisation to match a reference population, controlling for 
cardiovascular risk factors may help in discovering whether differences in CA 
incidence and outcomes between health systems are due to population differences, or 
differences in the health care provided. 
The proportions of shockable primary rhythms between IHCA and OHCA (Paper I) 
were remarkably similar, at 26.3% for IHCA and 25.9% for OHCA. Proportions of 
presumed cardiac aetiology were also similar, at 71.2% for IHCA and 65.3% for 
OHCA. The OHCA group has traditionally been dominated by acute myocardial 
infarction, which commonly presents with initial shockable rhythms.96 Improved 
prevention and an increasing use of implantable cardioverter defibrillators have 
reduced both incidence and severity of acute myocardial infarction.75, 94, 97-100 As a 
consequence, the OHCA group is less dominated by coronary disease, and probably 
more similar to the ICHA group now than previously. 
Many resuscitations from IHCA are undertaken in patients unlikely to survive.101 
Hence, policy on when not to attempt resuscitation will influence both IHCA 
incidence and outcome. There is an ongoing discussion in the UK regarding whether 
the initial presumption for CPR should remain, or if it may be better to replace it with 
a positive recommendation for CPR in a minority of patients.102 Such an alteration of 
policy would probably have a dramatic effect on CA incidence and outcome. In order 
to control for resuscitation policy, the ratio of IHCA incidence to total hospital 
mortality could be an indicator of interest. Hospital effectiveness in preventing and 
treating CA in specific high-risk populations, like patients admitted for acute 
coronary syndromes, is another indicator to consider.103 
 40 
5.2 Treatment 
Paper III shows that intensive care treatment including TTM in ordinary clinical 
practice compared to intensive care treatment without TTM may have a beneficial 
effect in terms of increased survival. The patients were treated with TTM at 33˚C for 
24 hours followed by rewarming to 37˚C at a rate of 0.5˚C per hour. Intensive care 
treatments included endotracheal intubation with mechanical ventilation, sedation in 
order to tolerate treatment and reduce oxygen consumption, haemodynamic 
optimization, treatment of seizures and prevention of pyrexia. Left ventricular assist 
devices in the form of impella or intra-aortic balloon pump were used for circulatory 
support when indicated at the discretion of the treating physician.  
The optimal duration and target temperature for TTM is unknown, but there is 
consensus that TTM to some degree is indicated in comatose OHCA survivors.45 A 
recent registry study found no benefit from TTM in IHCA, recommending a 
randomized trial in order to explore the question.104 It may be that TTM has effect 
only in patients who have suffered global brain ischemia. Recent trials have included 
patient groups with short periods of anoxia, where TTM is less likely to be of 
benefit.104, 105 An effect might be seen in patients with longer resuscitation times. 
To what extent improved outcomes from CA over the past decade are due to better 
intensive care treatment, standardized treatment protocols, introduction of TTM, or 
PCI is debated.106, 107 At present, there are probable but uncertain effects from TTM 
as well as primary PCI in CA. We may be back to the discoveries of Peter Safar and 
colleagues in the 1990s.108 They found an effect of hypertensive hemodilution and 
TTM combined, but no isolated effect of either. This may be the case in 
contemporary clinical research as well. The effects of available treatment on coarse 
indicators of outcome like mortality may be small, and easily offset by Hawthorne 
effects in clinical trials. One way to make treatment effects substantial enough to 
measure in a clinical setting is to combine several treatments in a bundle.109 A 
treatment bundle involving PCI, TTM, and general intensive care treatment improved 
survival, but gave no indication as to which factors contributed the most.110  
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Paper III is an example of how health registry data may be used to move the 
discussion forward by investigating causality based on registry data. Propensity score 
matching is a robust method, its advocates claiming that a well performed 
observational study closely resembles a randomized controlled trial.111 A prerequisite 
for matching is that some patients receive the treatment in question and others do not. 
These two populations differ because treatment is based on indications, a problem 
which has hampered observational studies and made policy makers reluctant to 
include them in systematic reviews. Matching methodology reduces the problem of 
differing populations by creating pairs or groups of subjects, one treated and one not 
treated, which are similar except for the treatment. After successful matching, the 
data may be used to infer causality. Propensity score matching uses the probability 
for treatment calculated from baseline covariates as the matching criterion. Baseline 
covariates must be measured before the start of treatment and must be likely to affect 
outcome. Although baseline covariates differ between two subjects, they may still be 
matched as long as the probability for treatment is similar. The result is two groups of 
patients, one treated and one not treated, in which the probability of treatment, i.e. the 
propensity score, is the same. The key feature of the propensity score is that the 
differences in baseline covariates between treatment and control patients in the 
unmatched sample tend to balance in the matched sample.111 Comparison of 
outcomes between the two groups therefore evaluates treatment effect and establishes 
causality. Critics of the method argue that confounders may exist which are unknown 
or unmeasured, and therefore not included in the model. These hidden confounders 
may either be responsible for or hide treatment effects. In order to reduce 
confounding, there are strict demands to methodology in propensity score analyses. 
All known confounders must be measured at baseline, before treatment allocation, 
and included in the analysis. Even so, observational studies will never be free of the 
potential confounder. This is why randomised studies are rated more highly than 
observational studies when grading the level of evidence. 
Survival from IHCA in paper I was similar to that of OHCA even though the IHCA 
population was older and presumably less healthy. We suspect that the immediate 
professional treatment of IHCA documented in the study is beneficial. If so, bringing 
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the experience and technology available in hospitals to the pre hospital stage might 
improve survival from OHCA. A recent meta-analysis comparing paramedic-led CPR 
to physician-led CPR showed increased survival for physician-led CPR.112 Whether 
this is due to the physicians knowledge or to her technical skills is not known. 
There is evidence that hospitals admitting more than 50 CA patients per year have 
better survival rates than hospitals with fewer admissions.113 This implies that 
adequate monitoring of circulation and experience with optimizing circulation in a 
setting with circulatory compromise is of importance. Further studies are needed to 
ensure that the effect is not due to selection bias, hospital or ICU size, or simply an 
artefact of the availability of more sophisticated treatment options. 
5.3 Outcome 
5.3.1 Survival 
In paper I, survival to hospital discharge from OHCA was 16.8%, or 10.2 per 100.000 
person-years, while survival from IHCA was 16.2%, or 6.7 per 100.000 person-years. 
As discussed previously, comparison of crude survival to hospital discharge between 
health systems is not generally advisable. Apart from differences in discharge policy, 
the lack of standardisation to a population norm causes bias. Further problems due to 
selection bias in terms of systematic exclusions and missing inclusions are discussed 
below in the section on limitations. 
Pooled mortality from CA in our community was 85.0 per 100.000 person-years, 
accounting for approximately two-thirds of the estimated cardiovascular mortality in 
our community.58, 114 The major remaining causes of cardiovascular mortality are 
heart failure and cerebrovascular disorders. 
Long-term survival (Paper II) was markedly decreased for patients discharged alive. 
Standardized mortality ratio from hospital discharge to start of the second study, 
compared with an age- and gender-matched Norwegian population, was 2.8. Most 
deaths occurred within the first six months after discharge. (Figure 6) 
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The reported increase in mortality is corrected for age and gender, but we know that 
cardiovascular risk factors and socioeconomic factors are likely to contribute.94, 99, 100 
Cardiovascular risk factors like smoking, obesity, diabetes mellitus, and physical 
inactivity are more prevalent in parts of society with lower socioeconomic status. 
Consequently, if socioeconomic status in the study sample was lower than the general 
Norwegian population, it could account for some of the increased mortality. One 
must also bear in mind possible effects of comorbidity in addition to risk factors and 
socioeconomic status. 
As there is a substantial number of deaths the first six months after discharge, some 
of them may be attributed to CA. A further aspect is that intensive care patients, 
regardless of the diagnosis which precipitates intensive care, have a higher mortality 
after hospital discharge compared to an age- and gender-matched normal 
population.115 It may be that some early deaths after discharge are due to intensive 
care treatment rather than CA. 
The choice of restricted mean survival time as the outcome measure in paper III 
complicates interpretation of the treatment effect. Restricted mean survival time was 
chosen because unlike hazard ratios, which are commonly used in similar studies, it 
does not depend on the proportional hazards assumption. Hazard ratios estimate 
Fig. 6. Survival after hospital discharge with 95 % pointwise confidence intervals.* 
     * Vertical lines indicate time of censoring. 
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survival at a single point in time: the time of follow-up. They assume, therefore, that 
the treatment effect is stable so that hazards do not change with time. If hazards do, in 
fact, change with time, the hazard ratio will depend on the time to follow-up. 
Consequently, the estimated treatment effect will depend on the chosen time to 
follow-up. Restricted mean survival time is more robust because survival during the 
entire period from inclusion to follow-up influences the mean. We chose to restrict 
survival time to 365 days after CA on the assumption that survival beyond one year 
likely depends more on other factors than CA.  
The question of whether a 57-day increase in restricted mean survival time is 
clinically significant remains, however. An impression of the magnitude of the 
difference can be gained from a study comparing the restricted mean survival time to 
hazard ratios in well-known cancer studies.116 The hazard ratios in the RE01 trial in 
advanced kidney cancer, the GOG111 trial in advanced ovarian cancer, and the 
IPASS trial in lung cancer were 0.73 / 0.75 / 0.73, respectively. Restricted mean 
survival times in the same three studies were 0.9 months / 3 months / 9 months, 
respectively, with corresponding follow-up times of 4 years / 7 years / 1.5 years. This 
indicates that the increase in restricted mean survival time of 57 days is clinically 
significant. 
5.3.2 Cognitive function 
When investigating long-term cognitive function in CA survivors in paper II, we 
identified MCI in 29% of patients with good cerebral function at hospital discharge 
according to the CPC classification. There is no general consensus regarding 
diagnostic criteria for MCI. However, the concept of MCI as a measurable deficit in 
at least one cognitive domain beyond that of normal aging with the absence of 
dementia is well established.117, 118 When defining cognitive impairment we used the 
Jackson criteria, classifying cognitive impairment as two out of ten results two 
standard deviations below the mean or three out of ten results 1.5 standard deviations 
below the mean.90 
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Cognitive testing revealed reduced episodic memory and a probable impact on 
executive function in CA survivors compared to the norm. Our findings correlate 
with the physiological substrate of damage to oxygen-sensitive neurons in the medial 
temporal lobe.119 Similar results from cognitive testing have been shown both over 
the short- and long-term using traditional neurocognitive tests, and over the short-
term using computerized tests.68, 120, 121 Rehabilitation of executive functioning is 
possible, whereas treatment of amnesia is limited.122 This might explain why 
executive functions were less affected than memory four years after CA.  
We assessed cognition using the CANTAB, a tablet-based computerized 
neuropsychological assessment device. Following its introduction by Sahakian and 
Robbins in the 1980s it has been increasingly used. Even so, there is discussion 
regarding computerized neuropsychological assessment devices compared with 
standard neuropsychological tests.123 Since CANTAB is a stand-alone solution there 
are no issues with compatibility with other software packages. Construct validity has 
been established in a Norwegian population, and we have chosen tests with high test-
retest correlations to achieve robustness.124-127 
The question of what CANTAB really measures remains, however. Studies 
investigating correlations between CANTAB and traditional neuropsychological test 
batteries find poor correlations between CANTAB tests purportedly assessing 
specific cognitive domains and their traditional neuropsychological counterparts.128 It 
is suggested that interaction with the computer interface may account for the 
discriminant ability of computerized neuropsychological assessment devices due to 
impairments in visual processing skills in MCI.129 Therefore, the most appropriate use 
of computerized neuropsychological assessment devices in CA survivors is as a 
screening tool in patients where MCI is suspected.124 
5.4 Strengths and limitations 
One strength of this dissertation lies in its attempt to combine emergency medicine, 
intensive care, epidemiology, and neuropsychology. These fields of research are 
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distinctly different with their own bodies of knowledge and differing methodologies. 
Data collection for papers I and II was prospective and thorough, using several data 
sources in order to identify cases and collect complete data sets. A further strength is 
the statistical methods used to evaluate treatment effect. 
It is a limitation that data for paper I, and in part for paper III, was collected from 
patient records. This is a problem affecting clinical research in general. The optimal 
solution in terms of data quality is to collect data prospectively and for study 
purposes only. This may be accomplished by making data collection forms and 
protocols for how to fill in each data point prior to the start of the study. The 
drawback is that compliance of clinical staff to fill in such forms is low, increasing 
the likelihood of both missing cases and missing data. Hiring staff dedicated to data 
collection is a possible solution, though not well suited to low incidence emergency 
conditions such as CA. Basing data collection on standard clinical documentation is 
another solution. This bypasses problems with compliance, but data not considered 
clinically relevant may be missing. The likelihood of inter-observer variability is also 
higher due to the lack of a strict protocol defining data elements. Our solution when 
collecting data for paper I was a hybrid between these two alternatives. Data 
collection forms for CA with protocols for their use existed as a standard in our 
patient journals. Nurses, physicians, and EMS personnel responsible for the 
documentation of CA were taught how to fill in these forms, and expected to do so 
for every CA. Personnel dedicated to the study checked that forms were filled in for 
relevant patients and that the data in each form was correct. This reduced the 
likelihood of both missing cases and missing data, while at the same time ensuring a 
protocol guided collection of data. 
Paper I is biased due to systematic exclusions because CA of less than three minutes’ 
duration during invasive cardiologic procedures were excluded due to methodological 
concerns. There are also few IHCA in the ICU and operative wards in the data set for 
paper I. This makes us suspect missing inclusions of IHCA in specialised wards. 
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It would have been advantageous if all data sets contained information about 
socioeconomic status, comorbidity, and cardiovascular risk factors. Such information 
would make comparison with other publications possible, and it would be possible to 
standardize the results according to these factors. Papers I and II would also have 
benefited from a better survival analysis. 
One may question the use of Z-scores to define cognitive impairment in paper II due 
to the small sample size and the fact that Fig. 2 in paper II suggests that the 
distributions may be skewed. A direct comparison of means would have been better. 
However, Z-scores are the only option for norms comparison in CANTAB.130 As a 
means of ascertaining the results from the t-tests, we conducted a bootstrap analysis 
as a sensitivity test. 
Lack of Norwegian population norms has led us to use Danish norms for EQ-5D and 
British norms for CANTAB, both of them close approximations of the parent 
population, in our opinion. 
The lack of temperature traces in paper III is a limitation, since the magnitude and 
profile of temperature differences between cases and controls is unknown to us. 
5.5 Perspectives 
The effects of cardiovascular risk factors, comorbidity, and socioeconomic status on 
CA incidence and survival need to be investigated further. This may be accomplished 
by monitoring IHCA and OHCA in a single population over time, and might also 
give insights into how prevention strategies and advances in treatment influence 
incidence and outcome from CA. 
The effects of physician-led CPR in OHCA should be further investigated as to 
whether increased survival is due to knowledge or technical skills.112 One could 
imagine that the physician has a better capability to diagnose the precipitating cause 
of CA than other health professionals. This is of particular importance when 
resuscitation is not successful during the first few cycles. The next natural step for a 
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physician would be to administer treatment based on the most probable diagnosis. A 
protocol which rapidly identifies the most likely precipitating cause of CA and tailors 
treatment accordingly could increase survival if good quality CPR is not lost. In order 
to aid diagnostic accuracy, one should consider the use of diagnostic tools during 
resuscitation. One such tool is ultrasonography, which is suggested to aid treatment of 
reversible causes of CA.131, 132 Continuous capnography readings might provide both 
diagnostic and prognostic information.133, 134 While mechanical chest compressions 
are not recommended as a standard initial setup, there is evidence of benefit later in 
the resuscitation phase.135 A setup with capnography in conjunction with controlled 
mechanical ventilation and controlled chest compressions would allow better 
standardization of respiratory minute volume and cardiac output. A pilot study, 
perhaps including autopsy, could indicate whether capnography in this setting 
provides information about the cause of CA or aids in prognostication. Analyses of 
arterial pH, lactate, and potassium would be of further interest in prognostication. 
An interesting development is the use of ECMO in CA, either as a bridge to treatment 
for a precipitating cause or as a bridge to recovery. Research in the field is, however, 
predominantly observational studies of low to moderate quality, rendering the effect 
of the intervention largely unknown. Due to the low number of available patients, 
comparison of ECMO CPR with standard CPR is initially best undertaken as registry 
studies using matching methodology in order to establish causality. 
Even though there seems to be no difference between TTM at 33˚C compared with 
36˚C, there are still questions to be answered regarding TTM. One question currently 
being investigated is the effect of early induction of TTM versus standard induction 
after admission. Currently, no strong evidence exists in favour of either.136 Studies on 
other methods for rapid induction of TTM are ongoing.137 A study investigating TTM 
of 48 hours’ duration compared with TTM of 24 hours’ duration is completed but not 
yet published.138 
There is some interest in the neuroprotective properties of inhaled agents. Xenon has 
shown neuroprotective properties in animal studies. In a recent human study, MRI 
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showed less white matter damage compared with controls, but there was no 
difference in survival or cognitive function.139 There is also an interest in the potential 
ameliorating effect of NO inhalations on cerebral and myocardial ischemia – 
reperfusion injuries that often follow CA.140 
Keeping in mind that recent randomized controlled studies of single interventions 
have failed to identify treatment effects, it may be that this is not the best method to 
identify improvements in the treatment of CA. One path to investigating the field 
further may be to conduct randomised controlled studies which investigate bundles 
rather than single treatments.109 A treatment bundle is a collection of evidence-based 
interventions applied to a patient category in order to improve outcome.141-143 Bundles 
of care rather than single interventions may increase the magnitude of treatment 
effects so that they are discernible from Hawthorne effects and other spurious effects 
which are difficult to control in a clinical setting.144Another path would be to look for 
natural opportunities to conduct high quality observational studies.145 When they are 
well designed, observational studies come close to randomized controlled trials in 
establishing causality.111 
Cognitive function and quality of life in CA survivors is a field where much is yet to 
be uncovered. In order to move forward, however, one has to establish consensus 
regarding which tools to use for measuring cognitive function and quality of life. At 
present the diversity of approaches hinders progress. The selected tools must be well 
validated, easy to use, and calibrated so that floor and ceiling effects are avoided. 
After selection of appropriate tools CA survivors should be compared to relevant 
control groups. For instance, survivors from CA with a cardiac cause could be 
compared to an age- and gender-matched population admitted to the ICU and treated 
for acute coronary syndrome during the same time period. Such a study could assess 
the temporal development of cognitive function and quality of life in CA survivors. If 
properly designed, the study could also investigate the effects of cognitive training.146  
An interesting consequence of recent discoveries linking the mental maps which aid 
spatial navigation with memory is the potential for physical activity in cognitive 
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rehabilitation.147-149 Position cells in the hippocampus and grid cells in the entorhinal 
cortex aid navigation, but they are also instrumental in creating memories.148 This 
link between memory and spatial perception might be a factor in explaining why 
visual processing skills are affected in MCI.146 The link also provides a theoretical 
basis for promising research regarding the cognitive abilities of MCI patients as a 
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8.1 Utstein data template 
Utstein data templates: summary of changes5 
1991 Name 2004 Name 2004 Definition 1991 Status 2004 Status 
1. Population 
served by EMS 
system 
Removed 
Total population of service 










Number of cardiac arrests 






Total number of cardiac 
arrests in which resuscitation 
was not attempted and number 













 Attempt was considered futile 
(or meaningless)   
  
 Signs of circulation were 




Total number of resuscitations 
attempted and number of these 




 Any defibrillation attempt 
  














Number of resuscitations in 
which etiology of arrest was 
Core Core 












Total number of resuscitation 










Number of resuscitation 
attempts in which arrest was 
witnessed by laypersons 
Core Core 




Number of resuscitation 
attempts in which arrest was 







Number of resuscitation 
attempts in which arrest was 




First monitored rhythm 
shockable 
Total number of resuscitation 
attempts in which first 
monitored rhythm was 





 Unknown AED shockable 
rhythm   
10. Initial rhythm 
VF 
See monitored rhythm 
shockable 
Number of resuscitation 
attempts in which first 
Core Core 
 63 
1991 Name 2004 Name 2004 Definition 1991 Status 2004 Status 
monitored rhythm after arrest 
was VF 
11. Initial rhythm 
VT 
See monitored rhythm 
shockable 
Number of resuscitation 
attempts in which first 




First monitored rhythm 
nonshockable 
Total number of resuscitation 
attempts in which first 
monitored rhythm was 








 Unknown AED nonshockable 
rhythm   
12. Initial rhythm 
asystole 
See first monitored 
rhythm nonshockable 
Number of resuscitation 
attempts in which first 
monitored rhythm after arrest 
was asystole 
Core Core 
13. Other initial 
rhythms 
See first monitored 
rhythm nonshockable 
Number of resuscitation 
attempts in which first 






yes or no for 
each subset 
CPR before EMS 
Number of resuscitation 
attempts in which CPR (chest 
compression) was performed 
before EMS arrival 
Core Core 
 
Rhythm analysis or 
defibrillation before 
EMS 
Number of resuscitation 
attempts in which either AED 
rhythm analysis or 
defibrillation was performed 
before EMS arrival 
None Core 
15. Any ROSC Any ROSC Number of resuscitation Core Core 
 64 
1991 Name 2004 Name 2004 Definition 1991 Status 2004 Status 












died en route to 
hospital 
Removed 
Number of resuscitation 
attempts in which all 
resuscitative efforts were 
discontinued and patient died 




died in ED 
Removed 
Number of resuscitation 
attempts in which all 
resuscitative efforts were 
discontinued and patient died 
in ED 
Core Supplementary 
18. Admitted to 
ICU/ward 
Survived event to 
ED/ICU 
Number of resuscitation 
attempts in which patient 
regained signs of circulation 






Number of resuscitation 
attempts in which patient 
regained signs of circulation 
and was admitted to ED/ICU 
but died in hospital 
Core Supplementary 




Number of resuscitation 
attempts in which patient 
regained signs of circulation 
and was admitted to ED/ICU 






Number of resuscitation 
attempts in which patient 
regained signs of circulation, 
Core Core 
 65 
1991 Name 2004 Name 2004 Definition 1991 Status 2004 Status 
was admitted to ED/ICU, and 
was discharged from hospital 
alive 
21. Died within 1 
year of hospital 
discharge 
Removed 
Number of resuscitation 
attempts in which patient 
regained signs of circulation, 
was discharged alive from 
hospital but died within 1 year 
from hospital discharge 
Core Supplementary 
22. Alive at 1 
year 
Removed 
Number of resuscitation 
attempts in which patient 
regained signs of circulation, 
was discharged alive from 
hospital, and was/is alive at 1 





Number of resuscitation 
attempts in which patient 
regained signs of circulation, 
was discharged alive from 
hospital, and had a CPC score 
of 
None Core 
 1 or 2 
 3 or 4 or unknown 
 
Location of arrest: out-
of-hospital 
Total number of resuscitations 
that took place out-of-hospital 
and number of resuscitation 






 Sport/recreation event 
 Street/highway 
 Public building 
 Assisted living/nursing home 




1991 Name 2004 Name 2004 Definition 1991 Status 2004 Status 
 
Location of arrest: in-
hospital 
Total number of resuscitation 
attempts that took place in-
hospital and number of 
resuscitation attempts that 






 Operating room 
 ICU 
 Other 
 Unknown   
 
 
